ONO PHARMACEUTICAL Co., Ltd. (4528.T) — English Disclosures

ONO PHARMACEUTICAL Co., Ltd. (4528.T) Prime Market English IR

All TDNet disclosures translated to English by Pulse News Wire.

Disclosures

Feb 2, 2026 — Mar 5, 2026

Date Range

PRIME

Market Segment

Pharmaceutical

Sector

Disclosures

Date	Type	Headline	PDF
Mar 5	Admin	ONO PHARMACEUTICAL TO ISSUE SHARES TO ESOP TRUST ON MARCH 25	PDF
Mar 5	Dividend	ONO PHARMACEUTICAL TO INTRODUCE LONG-TERM STOCK INCENTIVE PLAN FOR US SUBSIDIARY EMPLOYEES	PDF
Mar 2	Other	ONO PHARMACEUTICAL CO.,LTD. Announces Officer Appointments	PDF
Feb 2	Earnings	ONO PHARMACEUTICAL CO.,LTD. Reports Q3 FY2026 Earnings Presentation: Revenue of 1.08 trillion	PDF

Disclosure Types

Admin: 1 Dividend: 1 Other: 1 Earnings: 1

Frequently Asked Questions

Where can I read ONO PHARMACEUTICAL Co., Ltd.'s disclosures in English?

Pulse News Wire translates all TDNet filings for ONO PHARMACEUTICAL Co., Ltd. (4528.T) to English. 4 disclosures have been translated since Feb 2, 2026.

How many disclosures has ONO PHARMACEUTICAL Co., Ltd. filed on TDNet?

Pulse News Wire has translated 4 disclosures for ONO PHARMACEUTICAL Co., Ltd. since Feb 2, 2026.

Does ONO PHARMACEUTICAL Co., Ltd. publish English IR materials?

No. ONO PHARMACEUTICAL Co., Ltd. is listed on the PRIME Market and has no English disclosure requirement. Pulse News Wire is the only English-language source for these filings.

What types of disclosures has ONO PHARMACEUTICAL Co., Ltd. filed?

ONO PHARMACEUTICAL Co., Ltd. has filed the following types of disclosures on TDNet: Admin (1), Dividend (1), Other (1), Earnings (1).

English translations for all 4,436 JPX-listed companies.

Including the 2,300 Standard and Growth Market companies with no other English source.

See Pricing Browse Articles